Jul 9, 2024 | Blog, Events, Published Research
Chronic Lymphocytic Leukemia (CLL), a type of slow-growing cancer of the blood and bone marrow, accounts for 25-30 percent of all leukemia in the Western world and is the most common type of leukemia in adults, with over 100,000 new global incidence cases and over...
Jan 6, 2023 | Blog, Events, News, Published Research
In December, a contingent of our real-world data experts attended the 2022 Annual Meeting of the American Society of Hematology. Led by Chief Scientific Officer Jeffrey Brown and Senior Vice President, TriNetX Oncology GmbH Lenka Kellerman, our team spent their time...
Oct 31, 2019 | Events, Press Releases
Cambridge, MA, October 31, 2019 — TriNetX, the global health research network that revolutionizes clinical research and enables discoveries through the generation of real-world evidence (RWE), today announced that it will present nine new research findings at the...
May 6, 2019 | Events, Press Releases
Cambridge, MA, May 6, 2019 — TriNetX, the global health research network that optimizes clinical research and enables discoveries through the generation of real-world evidence (RWE), today announced that it will present eight posters at the upcoming International...
May 14, 2018 | Events, Press Releases
CAMBRIDGE, MA – May 14, 2018 – TriNetX™, the global health research network, today announced that it willpresent three posters on the use of real-world data from its federated electronic medical record (EMR)-based network as an established methodology for evaluating...